Hexagon Nutrition IPO

The company manufactures and markets:

• Micronutrient premixes

• Therapeutic nutrition products

• Clinical nutrition formulations

• Fortified food ingredients

• Vitamin and mineral blends

• Nutraceutical ingredients

• Sports nutrition solutions

• Pediatric and maternal nutrition products

Hexagon Nutrition has manufacturing operations across:

• Maharashtra

• Tamil Nadu

• Uzbekistan

Its products are sold across India and international markets through B2B and institutional channels.

The IPO is entirely an Offer for Sale (OFS) of up to 30.85 million equity shares, meaning the company itself will not receive fresh capital from the issue.

India’s nutrition and wellness industry has been growing rapidly due to rising health awareness, preventive healthcare adoption, and increasing demand for fortified foods.

The company operates at the intersection of:

• Nutraceuticals

• Functional foods

• Micronutrient fortification

• Clinical nutrition

• Wellness ingredients

Key Industry Drivers

Rising Lifestyle Diseases

India has witnessed a sharp increase in:

• Diabetes

• Obesity

• Heart diseases

• Nutritional deficiencies

This has increased consumer demand for preventive nutrition products.

Government Nutrition Programs

Government-backed initiatives such as:

• Poshan Abhiyaan

• Food fortification programs

• Mid-day meal nutrition standards

• Anemia reduction campaigns

have improved long-term demand visibility for nutrition ingredient manufacturers.

Expanding Nutraceutical Market

India’s nutraceutical market is estimated to grow at a double-digit CAGR over the next few years, driven by:

• Sports nutrition

• Immunity products

• Pediatric supplements

• Women’s wellness

• Clinical nutrition

Export Opportunity

Global demand for customized nutrition blends and fortified ingredients is increasing as food manufacturers focus on healthier product formulations.

Hexagon benefits from:

• Manufacturing scale

• Technical formulation capability

• Regulatory approvals

• Export presence

Hexagon Nutrition operates as a specialized nutrition science company rather than a traditional FMCG player.

Its business model is largely B2B-driven.

Core Revenue Segments

Micronutrient Premixes

Customized vitamin and mineral blends supplied to:

• Food companies

• Pharma companies

• Nutraceutical brands

Therapeutic Nutrition

Products designed for:

• Hospitals

• Clinical nutrition

• Disease management

Food Fortification

The company develops ingredients used in:

• Fortified flour

• Rice

• Dairy products

• Beverages

Consumer Nutrition

The business also caters to wellness-focused retail nutrition categories.

Manufacturing Footprint

The company operates multiple facilities including:

The diversified manufacturing setup reduces geographical concentration risk while improving export servicing capability.

The nutrition and nutraceutical industry is highly regulated because products directly impact public health.

Hexagon Nutrition operates under multiple regulatory frameworks including:

• FSSAI regulations

• Nutraceutical product standards

• Export compliance norms

• Environmental approvals

• Factory licenses

• Drug-related manufacturing standards in specific categories

The company also requires compliance related to:

• Product labeling

• Ingredient disclosures

• Food safety testing

• Packaging standards

• Import-export regulations

Failure to comply can lead to:

• Product recalls

• Penalties

• Suspension of approvals

• Export restrictions

Investors should evaluate the business beyond the growth narrative.

Key Risks

Raw Material Volatility

The company depends on vitamins, minerals, amino acids, and specialty nutrition ingredients whose prices can fluctuate significantly.

Global supply disruptions may impact margins.

Regulatory Risk

Changes in food safety standards or ingredient restrictions can affect product approvals and commercialization timelines.

Customer Concentration

A significant portion of revenue may come from institutional or large B2B customers.

Loss of key clients may affect growth.

Forex Exposure

Export operations expose the company to currency fluctuation risks.

Competitive Industry

The nutrition market includes:

• Global ingredient companies

• Domestic nutraceutical players

• Specialized premix manufacturers

Pricing pressure may impact profitability.

OFS Nature of IPO

Since the issue is entirely an Offer for Sale, the company itself will not receive fresh funds for expansion.

This is an important consideration for long-term investors.

The company is promoted by the Kelkar family.

Promoters

• Arun Purushottam Kelkar

• Subhash Purushottam Kelkar

• Vikram Arun Kelkar

• Nikhil Arun Kelkar

• Aditya Kelkar

The promoter family has decades of experience in nutrition ingredients, food science, and healthcare-focused manufacturing.

The company has multiple subsidiaries operating across nutrition and international markets.

Subsidiaries

• Hexagon Nutrition (International) Private Limited

• Hexagon Nutrition Healthcare Private Limited

• Hexagon Nutrition Proprietary Limited

• Hexagon Nutrition LLC

• Hexagon Nutrition China Limited

The international structure supports export growth and overseas distribution capabilities.

The company’s management combines promoter leadership with operational professionals.

Key Leadership

The second-generation leadership appears actively involved in scaling international operations and product diversification.

The company has established standard governance committees including:

• Audit Committee

• Nomination & Remuneration Committee

• CSR Committee

• Risk Management Committee

• Stakeholders’ Relationship Committee

For investors, strong governance becomes particularly important in healthcare and nutrition businesses because of product safety sensitivity.

The company has disclosed ongoing legal and regulatory matters in the offer document.

These include:

• Tax-related proceedings

• Commercial disputes

• Regulatory compliance matters

• Corporate proceedings

Investors should evaluate:

• Monetary exposure

• Probability of adverse outcomes

• Impact on operations

No unusually alarming litigation appears to threaten business continuity based on disclosed information, though investors should monitor material developments.

Hexagon Nutrition requires various operational approvals including:

• Factory licenses

• Pollution control approvals

• Food safety certifications

• Import-export registrations

• GST registrations

• International certifications

Such approvals are critical because nutrition manufacturing is compliance intensive.

Hexagon Nutrition has demonstrated steady business scale-up supported by rising demand for nutrition and wellness products.

Financial Observations

Revenue Growth

The company has reported improving revenue trends over recent years due to:

• Export expansion

• Higher nutrition demand

• Product diversification

• Institutional business growth

Profitability

Margins appear supported by:

• Specialized formulations

• Value-added products

• Technical manufacturing capability

However, raw material inflation remains a margin risk.

Operational Efficiency

The company benefits from:

• Integrated production capability

• Multiple manufacturing locations

• International presence

This improves scalability and customer servicing.

The company carries borrowings related to:

• Working capital

• Manufacturing expansion

• Business operations

Nutrition businesses generally require substantial working capital because:

• Raw material imports are inventory intensive

• Customer credit cycles can be lengthy

• Specialized ingredients require stocking

Investors should monitor:

• Debt-to-equity ratio

• Interest coverage

• Working capital efficiency

Cash flow quality is an important indicator for manufacturing companies.

Key observations include:

• Operating cash flow generation from core operations

• Working capital dependence due to inventory requirements

• Capex spending for manufacturing expansion

Sustainable operating cash flow will be important for future scalability.

Hexagon Nutrition’s strategy appears focused on long-term structural nutrition trends.

Key Strategic Priorities

Product Innovation

Developing specialized nutrition formulations with higher margins.

Export Expansion

Growing international presence through overseas subsidiaries and distribution networks.

Institutional Partnerships

Supplying nutrition products for healthcare and public nutrition programs.

Capacity Expansion

Scaling manufacturing capabilities to meet rising demand.

Wellness Market Positioning

Targeting preventive healthcare and wellness categories.

This IPO is entirely an Offer for Sale.

That means:

• Existing shareholders are selling shares

• The company will not receive fresh proceeds

• No direct capital infusion will occur

This is a critical factor for investors evaluating future growth funding.

The pricing of the IPO is expected to consider:

• Revenue growth

• Profitability trends

• Nutrition industry outlook

• Peer valuation multiples

• Export opportunity

• Brand positioning

Nutrition and nutraceutical companies often trade at premium valuations because of:

• High-growth potential

• Wellness sector demand

• Better margins compared to commodity food businesses

However, investors should compare valuation with listed peers in:

• Nutraceuticals

• Specialty food ingredients

• Healthcare nutrition

Before the IPO, the company is largely promoter-owned through the Kelkar family and related entities.

Selling Shareholders

Subhash Purushottam Kelkar is the largest selling shareholder in the issue.

The post-listing structure is expected to improve:

• Public float

• Institutional participation

• Market visibility

• Liquidity in the stock

The company has disclosed a formal dividend policy for shareholders.

Future dividend decisions will depend on:

• Profitability

• Cash flows

• Expansion requirements

• Working capital needs

• Debt obligations

Since nutrition manufacturing remains growth-oriented, retained earnings may continue to be prioritized for expansion over aggressive dividend payouts.

The company has entered into related party transactions during the normal course of business.

These may include:

• Sale and purchase transactions

• Rent agreements

• Inter-company services

• Loans or advances

• Business support arrangements

For investors, the important aspect is whether:

• Transactions are conducted at arm’s length

• Proper approvals exist

• Governance standards are maintained

No major governance red flags appear from the disclosed related party framework.

Hexagon Nutrition has entered into several material agreements critical for operations.

These include:

• Supply agreements

• Manufacturing contracts

• Export arrangements

• Distribution partnerships

• Technology-related arrangements

• Banking and financing agreements

The continuity of these agreements is important for maintaining:

• Revenue visibility

• Customer relationships

• Production continuity

Post listing, equity shareholders will receive standard shareholder rights under Indian corporate law.

Shareholder Rights Include

• Voting rights

• Dividend entitlement

• Participation in bonus issues

• Rights issue participation

• Access to annual reports

• Participation in shareholder meetings

Minority shareholder protection provisions under SEBI and Companies Act regulations will also apply after listing.

The company has disclosed various statutory matters including:

• Capital structure

• Material contracts

• Litigation details

• Regulatory approvals

• Corporate governance disclosures

• Financial disclosures

• Promoter information

The company has also received in-principle approvals from:

• NSE

• BSE

for listing of equity shares.

Hexagon Nutrition operates in a structurally attractive segment linked to:

• Preventive healthcare

• Nutraceuticals

• Food fortification

• Wellness consumption

• Clinical nutrition

The business benefits from:

• Multi-location manufacturing

• Export exposure

• Specialized nutrition expertise

• Long operating history

• Diversified product portfolio

Positives

• Strong positioning in nutrition and wellness

• Export opportunity

• Growing health-conscious consumer trends

• Institutional nutrition demand

• Manufacturing scale

• Experienced promoters

Key Concerns

• Entire IPO is OFS

• Raw material price volatility

• Competitive industry landscape

• Regulatory sensitivity

• Working capital-intensive operations

For long-term investors, the company offers exposure to India’s growing nutrition and wellness ecosystem, though valuation and margin sustainability will remain key monitorable factors after listing.